Trontinemab, CAS 2568868-35-7

Product Description: Trontinemab is a bispecific and humanizedized IgG1-κ antibody, targeting to amyloid beta A4 precursor protein (APP) and transferrin receptor, p90, CD71 (TFRC). Trontinemab can be used for research on Alzheimer disease (AD)[1][2].

Applications: Neuroscience-Neurodegeneration

Formula: N/A

References: [1]Trontinemab. IMGT/mAb-DB./[2]Duggan MR, et al. Herpes Viruses in the Baltimore Longitudinal Study of Aging: Associations With Brain Volumes, Cognitive Performance, and Plasma Biomarkers. Neurology. 2022 Aug 19;99(18):e2014–24.

CAS Number: 2568868-35-7

Molecular Weight: N/A

Compound Purity: 96.77

Research Area: Neurological Disease

Solubility: 10 mM in DMSO/H2O

Target: Amyloid-β

• Artikelnummer: MEXHY-P9999-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9999-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated